Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression
Preprint in medRxiv (January 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis
Article in Endocrine Practice (November 2023)
Diabetes Mellitus in Acute Coronary Syndrome
Article in Life (November 2023)